Jim Simons acquired 294 Thousand Eagle Pharmaceuticals shares worth $1.25 Million. That's 0.00% of their equity portfolio (2127th largest holding). The investor owns 2.15% of the outstanding Eagle Pharmaceuticals stock. The first Eagle Pharmaceuticals trade was made in Q1 2015. Since then Jim Simons bought shares eleven more times and sold shares on nine occasions. The investor's estimated purchase price is $13.6 Million, resulting in a loss of 91%.